Similarly, aberrantly increased GLDC expression is associated with poor prognosis and accelerates cell proliferation, invasion, metastasis and immune escape in multiple cancers, including neuroblastoma, glioma and prostate cancer [[14], [15], [16]]. This evidence concerns the gene GLDC and central nervous system cancer.